Go to Page # Page of 21

BTG Strategy, Development, Building Value

Description: UBS Global Life Sciences Conference, Strategy to deliver sustainable profitability, Leveraging our new US commercial operations, Varisolve varicose veins, Voraxaze finalizing BLA submission, BGC20-0134 (Pleneva) Phase IIa progress, OncoGel phase IIb progress, Future value drivers in licensed pipeline, Robust business model, Building a major specialty pharmaceuticals business
Views: 2381
Domain: Business
Category: Companies
UBS Gl b l Lif S i Global Life Sciences C f Conference
September 2010

Forward-looking statements

This presentation and information communicated verbally to you may contain certain projections and other forward-looking statements with respect to the financial condition condition, results of operations, businesses and prospects of BTG plc ("BTG"). These statements are based on current expectation ... See more

Recent Presentations

Christopher Tse
19 April, 2019

Belimo Company Presentation

The Belimo Group is a leading global manufacturer of an innovative electrical actuator, valve and sensor solutions for heating, ventilation and air conditioning systems.

18 April, 2019

Assessing the Gains from E-Commerce

E-Commerce represents rapidly growing share of consumer spending in U.S. Using transactions-level data on credit & debit cards from Visa, Inc. between 2007 and 2017.

17 April, 2019